Trexquant Investment LP Purchases 168,475 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• Trexquant Investment LP significantly increased its stake in GE HealthCare Technologies by 274.6% in the first quarter, acquiring 168,475 shares to own a total of 229,836 shares valued at approximately $18.55 million.
• Wall Street analysts have predominantly rated GE HealthCare Technologies as a "Moderate Buy", with eight analysts issuing buy ratings and a consensus target price of $88.55.
• The company recently announced a quarterly dividend of $0.035 per share, translating to an annual yield of 0.2%, highlighting a modest but steady return for investors.

Trexquant Investment LP grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 274.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 229,836 shares of the company's stock after acquiring an additional 168,475 shares during the quarter. Trexquant Investment LP owned about 0.05% of GE HealthCare Technologies worth $18,550,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of GEHC. JPMorgan Chase & Co. grew its holdings in shares of GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company's stock valued at $414,894,000 after purchasing an additional 1,711,963 shares in the last quarter. Eminence Capital LP purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $102,574,000. BNP Paribas Financial Markets purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $76,093,000. Nuveen LLC purchased a new position in shares of GE HealthCare Technologies in the first quarter valued at $77,058,000. Finally, GAMMA Investing LLC grew its holdings in shares of GE HealthCare Technologies by 9,524.6% in the first quarter. GAMMA Investing LLC now owns 771,507 shares of the company's stock valued at $62,268,000 after purchasing an additional 763,491 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.0%

Shares of NASDAQ:GEHC traded up $0.01 on Friday, hitting $73.73. 1,982,987 shares of the company's stock were exchanged, compared to its average volume of 2,963,169. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market capitalization of $33.66 billion, a price-to-earnings ratio of 15.11, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13. The business's 50 day simple moving average is $74.23 and its two-hundred day simple moving average is $74.55. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the company earned $1.00 earnings per share. The business's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.87%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on GEHC shares. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Morgan Stanley lowered their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday. Finally, Citigroup raised their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $88.55.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.